Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

CONZIP

TRAMADOL HYDROCHLORIDE

Standard Dose
300MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CONZIP is listed in Drugs@FDA under application 022370 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TRAMADOL HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 300MG Sponsor CIPHER PHARMS INC Submission history Latest submission status date: 2025-12-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview CONZIP is listed in Drugs@FDA under application 022370 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TRAMADOL HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 300MG Sponsor CIPHER PHARMS INC Submission history Latest submission status date: 2025-12-22 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.